iiinova — where your digital self keeps evolving

Reposted by Lauri Ivaska

MedPage Today @medpagetoday.com · 25/09/2026

Maternal Tdap vaccination helps protect young infants from pertussis, but it was seen to blunt infants' response to their own primary DTaP vaccination in a small observational study. @lauriivaska.bsky.social www.medpagetoday.com/pediatrics/vac…

medpagetoday.com

Maternal Tdap Blunts Preschoolers' Pertussis Shot Response, but Booster Revives Them

A DTaP booster at age 4 brought immune responses level with kids of unvaccinated moms

021

Lauri Ivaska @lauriivaska.bsky.social · 28/10/2025

Last call 📣 for immunologists interested in a postdoc-project related to immunogenicity of pertussis vaccination: Submit your application to Qiushui He or to Tapio Lönnberg by 31/10/2025 for a 3-year fellowship position supported by the prestigious MSCA COFUND programme #IMMUFELLOW #uniturku

010

Lauri Ivaska @lauriivaska.bsky.social · 23/10/2025

Fully funded 3-year SC immunogenomic project related to pertussis vaccine responses at #uniturku (supported by the MSCA COFUND). Apply! www.linkedin.com/posts/lauri-... immufellow.fi

immufellow.fi

Home - IMMUFELLOW

IMMUFELLOW NEWS & EVENTS The Interdisciplinary and Intersectoral Research Fellowship Programme for Future Leaders in Immunology (IMMUFELLOW) is an innovative

011

Reposted by Lauri Ivaska

Eurosurveillance journal @eurosurveillance.org · 06/12/2024

During this ongoing #pertussis outbreak in Finland, Miettinen et al. observed a considerable increase in the age groups of 10–14 & 15–19 years compared with age distributions in 2019 Macrolide resistance identified in Finland is similar to the one reported from France IDsky PedsSky 🩺 #PublicHealth

2104

Reposted by Lauri Ivaska

Eurosurveillance journal @eurosurveillance.org · 05/12/2024

Our new issue is available with a special appearance by, again, Escherichia coli 🦠 bit.ly/eus2949 💉 EpiSky #IDSky MicroSky #PublicHealth ⚕️🧪🩺

Image depicting the table of content of issue 49 in 2024, published 5 December 2024:

Rapid communication
Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024

Outbreaks
Persistence of OXA-48-producing ST-22 Citrobacter freundii in patients and the hospital environment, Paris, France, 2016 to 2022

Systematic Review
Reasons for difficulties in isolating the causative organism during food-borne outbreak investigations using STEC as a model pathogen: a systematic review, 2000 to 2019

Perspective
Cross-sectoral genomic surveillance reveals a lack of insight in sources of human infections with Shiga toxin-producing Escherichia coli, the Netherlands, 2017 to 2023

Letter
Vaccinating against the absent: Risks of the B/Yamagata strain in the live attenuated vaccine

173